Microbot Medical Inc. (MBOT)
USD 0.97
(-3.69%)
USD 0.97
(-3.69%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.82 Million USD | 70.2% |
| 2022 | 2.24 Million USD | -5.78% |
| 2021 | 2.38 Million USD | 21.06% |
| 2020 | 1.97 Million USD | -64.72% |
| 2019 | 5.58 Million USD | 17.16% |
| 2018 | 4.76 Million USD | 351.52% |
| 2017 | 1.05 Million USD | -36.84% |
| 2016 | 1.67 Million USD | -92.24% |
| 2015 | 21.55 Million USD | -18.84% |
| 2014 | 26.55 Million USD | -0.18% |
| 2013 | 26.6 Million USD | 64.36% |
| 2012 | 16.18 Million USD | 11.78% |
| 2011 | 14.48 Million USD | -4.24% |
| 2010 | 15.12 Million USD | -26.94% |
| 2009 | 20.69 Million USD | 6.56% |
| 2008 | 19.42 Million USD | 48.59% |
| 2007 | 13.07 Million USD | 4.73% |
| 2006 | 12.48 Million USD | 0.14% |
| 2005 | 12.46 Million USD | 16.72% |
| 2004 | 10.67 Million USD | 21.02% |
| 2003 | 8.82 Million USD | 16.99% |
| 2002 | 7.54 Million USD | -0.71% |
| 2001 | 7.59 Million USD | 11.48% |
| 2000 | 6.81 Million USD | -7.0% |
| 1999 | 7.32 Million USD | -51.16% |
| 1998 | 15 Million USD | 61.29% |
| 1997 | 9.3 Million USD | -60.76% |
| 1996 | 23.7 Million USD | 107.89% |
| 1995 | 11.4 Million USD | 18.75% |
| 1994 | 9.6 Million USD | 47.69% |
| 1993 | 6.5 Million USD | 8.33% |
| 1992 | 6 Million USD | 150.0% |
| 1991 | 2.4 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.2 Million USD | -68.64% |
| 2024 Q2 | 1.37 Million USD | 14.92% |
| 2023 Q4 | 3.82 Million USD | 150.07% |
| 2023 Q2 | 1.41 Million USD | 4.12% |
| 2023 Q1 | 1.36 Million USD | -39.5% |
| 2023 FY | 3.82 Million USD | 70.2% |
| 2023 Q3 | 1.53 Million USD | 8.05% |
| 2022 Q4 | 2.24 Million USD | 19.83% |
| 2022 Q1 | 2.06 Million USD | -13.62% |
| 2022 FY | 2.24 Million USD | -5.78% |
| 2022 Q3 | 1.87 Million USD | -6.29% |
| 2022 Q2 | 2 Million USD | -2.86% |
| 2021 Q2 | 1.74 Million USD | -5.05% |
| 2021 Q1 | 1.84 Million USD | -6.65% |
| 2021 FY | 2.38 Million USD | 21.06% |
| 2021 Q4 | 2.38 Million USD | 30.31% |
| 2021 Q3 | 1.83 Million USD | 4.81% |
| 2020 FY | 1.97 Million USD | -64.72% |
| 2020 Q2 | 1.51 Million USD | -6.3% |
| 2020 Q3 | 1.54 Million USD | 1.98% |
| 2020 Q1 | 1.62 Million USD | -71.0% |
| 2020 Q4 | 1.97 Million USD | 27.33% |
| 2019 Q2 | 4.59 Million USD | -1.82% |
| 2019 Q3 | 4.72 Million USD | 2.74% |
| 2019 Q1 | 4.67 Million USD | -1.87% |
| 2019 FY | 5.58 Million USD | 17.16% |
| 2019 Q4 | 5.58 Million USD | 18.35% |
| 2018 Q3 | 1.06 Million USD | -2.93% |
| 2018 FY | 4.76 Million USD | 351.52% |
| 2018 Q1 | 983 Thousand USD | -6.91% |
| 2018 Q2 | 1.09 Million USD | 11.29% |
| 2018 Q4 | 4.76 Million USD | 348.96% |
| 2017 Q4 | 1.05 Million USD | 0.96% |
| 2017 Q3 | 1.04 Million USD | -19.91% |
| 2017 Q2 | 1.3 Million USD | -26.96% |
| 2017 FY | 1.05 Million USD | -36.84% |
| 2017 Q1 | 1.78 Million USD | 6.94% |
| 2016 FY | 1.67 Million USD | -92.24% |
| 2016 Q1 | 24.27 Million USD | 12.61% |
| 2016 Q2 | 11.21 Million USD | -53.8% |
| 2016 Q4 | 1.67 Million USD | -60.81% |
| 2016 Q3 | 4.26 Million USD | -61.96% |
| 2015 FY | 21.55 Million USD | -18.84% |
| 2015 Q1 | 23.59 Million USD | -11.15% |
| 2015 Q2 | 21.72 Million USD | -7.94% |
| 2015 Q3 | 21.27 Million USD | -2.06% |
| 2015 Q4 | 21.55 Million USD | 1.32% |
| 2014 Q2 | 30.9 Million USD | 5.93% |
| 2014 Q4 | 26.55 Million USD | -1.74% |
| 2014 Q1 | 29.17 Million USD | 9.66% |
| 2014 FY | 26.55 Million USD | -0.18% |
| 2014 Q3 | 27.02 Million USD | -12.55% |
| 2013 Q3 | 28.75 Million USD | 13.69% |
| 2013 Q4 | 26.6 Million USD | -7.49% |
| 2013 FY | 26.6 Million USD | 64.36% |
| 2013 Q1 | 14.55 Million USD | -10.07% |
| 2013 Q2 | 25.29 Million USD | 73.77% |
| 2012 Q2 | 11.58 Million USD | -35.39% |
| 2012 Q3 | 20.43 Million USD | 76.32% |
| 2012 Q4 | 16.18 Million USD | -20.79% |
| 2012 FY | 16.18 Million USD | 11.78% |
| 2012 Q1 | 17.93 Million USD | 23.88% |
| 2011 Q3 | 8.48 Million USD | -10.3% |
| 2011 Q1 | 12.2 Million USD | -19.32% |
| 2011 Q4 | 14.48 Million USD | 70.66% |
| 2011 FY | 14.48 Million USD | -4.24% |
| 2011 Q2 | 9.45 Million USD | -22.47% |
| 2010 Q1 | 17.27 Million USD | -16.53% |
| 2010 FY | 15.12 Million USD | -26.94% |
| 2010 Q4 | 15.12 Million USD | 19.59% |
| 2010 Q3 | 12.64 Million USD | -12.39% |
| 2010 Q2 | 14.43 Million USD | -16.46% |
| 2009 Q1 | 21.83 Million USD | 12.42% |
| 2009 FY | 20.69 Million USD | 6.56% |
| 2009 Q4 | 20.69 Million USD | 5.03% |
| 2009 Q3 | 19.7 Million USD | -12.13% |
| 2009 Q2 | 22.42 Million USD | 2.71% |
| 2008 Q1 | 10.77 Million USD | -17.57% |
| 2008 FY | 19.42 Million USD | 48.59% |
| 2008 Q4 | 19.42 Million USD | 82.9% |
| 2008 Q3 | 10.61 Million USD | -4.23% |
| 2008 Q2 | 11.08 Million USD | 2.91% |
| 2007 Q1 | 11.89 Million USD | -4.69% |
| 2007 Q2 | 11.58 Million USD | -2.6% |
| 2007 FY | 13.07 Million USD | 4.73% |
| 2007 Q4 | 13.07 Million USD | 5.11% |
| 2007 Q3 | 12.43 Million USD | 7.33% |
| 2006 Q1 | 11.93 Million USD | -4.27% |
| 2006 Q3 | 11.54 Million USD | -5.72% |
| 2006 FY | 12.48 Million USD | 0.14% |
| 2006 Q2 | 12.24 Million USD | 2.63% |
| 2006 Q4 | 12.48 Million USD | 8.12% |
| 2005 Q1 | 10.09 Million USD | -5.5% |
| 2005 FY | 12.46 Million USD | 16.72% |
| 2005 Q2 | 10.93 Million USD | 8.33% |
| 2005 Q4 | 12.46 Million USD | 12.59% |
| 2005 Q3 | 11.06 Million USD | 1.26% |
| 2004 Q1 | 8.45 Million USD | -4.15% |
| 2004 FY | 10.67 Million USD | 21.02% |
| 2004 Q2 | 8.42 Million USD | -0.34% |
| 2004 Q3 | 10.19 Million USD | 20.94% |
| 2004 Q4 | 10.67 Million USD | 4.76% |
| 2003 Q4 | 8.82 Million USD | 31.83% |
| 2003 Q1 | 7.88 Million USD | 4.55% |
| 2003 Q3 | 6.69 Million USD | -0.87% |
| 2003 Q2 | 6.75 Million USD | -14.37% |
| 2003 FY | 8.82 Million USD | 16.99% |
| 2002 Q1 | 8.09 Million USD | 6.58% |
| 2002 FY | 7.54 Million USD | -0.71% |
| 2002 Q4 | 7.54 Million USD | -15.59% |
| 2002 Q3 | 8.93 Million USD | 8.76% |
| 2002 Q2 | 8.21 Million USD | 1.47% |
| 2001 Q3 | 5.41 Million USD | -12.35% |
| 2001 Q4 | 7.59 Million USD | 40.34% |
| 2001 FY | 7.59 Million USD | 11.48% |
| 2001 Q1 | 6.04 Million USD | -11.27% |
| 2001 Q2 | 6.17 Million USD | 2.15% |
| 2000 Q1 | 4.97 Million USD | -32.04% |
| 2000 FY | 6.81 Million USD | -7.0% |
| 2000 Q2 | 4.78 Million USD | -3.94% |
| 2000 Q3 | 4.5 Million USD | -5.8% |
| 2000 Q4 | 6.81 Million USD | 51.22% |
| 1999 Q4 | 7.32 Million USD | -33.4% |
| 1999 Q1 | 12.4 Million USD | -17.33% |
| 1999 FY | 7.32 Million USD | -51.16% |
| 1999 Q2 | 11.8 Million USD | -4.84% |
| 1999 Q3 | 11 Million USD | -6.78% |
| 1998 Q4 | 15 Million USD | 10.29% |
| 1998 Q2 | 17.1 Million USD | 113.75% |
| 1998 Q1 | 8 Million USD | -13.98% |
| 1998 FY | 15 Million USD | 61.29% |
| 1998 Q3 | 13.6 Million USD | -20.47% |
| 1997 FY | 9.3 Million USD | -60.76% |
| 1997 Q2 | 19.7 Million USD | -15.81% |
| 1997 Q3 | 22.1 Million USD | 12.18% |
| 1997 Q4 | 9.3 Million USD | -57.92% |
| 1997 Q1 | 23.4 Million USD | -1.27% |
| 1996 FY | 23.7 Million USD | 107.89% |
| 1996 Q4 | 23.7 Million USD | 78.2% |
| 1996 Q3 | 13.3 Million USD | 17.7% |
| 1996 Q1 | 9.5 Million USD | -16.67% |
| 1996 Q2 | 11.3 Million USD | 18.95% |
| 1995 Q2 | 11.6 Million USD | 4.5% |
| 1995 FY | 11.4 Million USD | 18.75% |
| 1995 Q4 | 11.4 Million USD | 1.79% |
| 1995 Q3 | 11.2 Million USD | -3.45% |
| 1995 Q1 | 11.1 Million USD | 15.63% |
| 1994 Q1 | 6.1 Million USD | -6.15% |
| 1994 Q4 | 9.6 Million USD | 41.18% |
| 1994 Q3 | 6.8 Million USD | 9.68% |
| 1994 Q2 | 6.2 Million USD | 1.64% |
| 1994 FY | 9.6 Million USD | 47.69% |
| 1993 Q2 | 5.7 Million USD | -6.56% |
| 1993 Q4 | 6.5 Million USD | 0.0% |
| 1993 FY | 6.5 Million USD | 8.33% |
| 1993 Q1 | 6.1 Million USD | 1.67% |
| 1992 Q4 | 6 Million USD | 0.0% |
| 1992 FY | 6 Million USD | 150.0% |
| 1991 Q4 | 2.4 Million USD | 0.0% |
| 1991 FY | 2.4 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 126.59 Million USD | 96.978% |
| AngioDynamics, Inc. | 112.08 Million USD | 96.587% |
| AtriCure, Inc. | 147.76 Million USD | 97.411% |
| Avinger, Inc. | 19.97 Million USD | 80.843% |
| Azenta, Inc. | 351.22 Million USD | 98.911% |
| BioLife Solutions, Inc. | 75.05 Million USD | 94.902% |
| The Cooper Companies, Inc. | 4.1 Billion USD | 99.907% |
| Daxor Corporation | 858.75 Thousand USD | -345.527% |
| Ekso Bionics Holdings, Inc. | 16.31 Million USD | 76.545% |
| Femasys Inc. | 9.4 Million USD | 59.312% |
| GlucoTrack, Inc. | 1.7 Million USD | -124.005% |
| Harvard Bioscience, Inc. | 64.29 Million USD | 94.049% |
| Hologic, Inc. | 4.02 Billion USD | 99.905% |
| ICU Medical, Inc. | 2.25 Billion USD | 99.83% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | 99.813% |
| KORU Medical Systems, Inc. | 8.1 Million USD | 52.807% |
| LeMaitre Vascular, Inc. | 48.87 Million USD | 92.172% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -479.753% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -479.753% |
| Masimo Corporation | 1.67 Billion USD | 99.772% |
| Meihua International Medical Technologies Co., Ltd. | 25.07 Million USD | 84.743% |
| Merit Medical Systems, Inc. | 1.12 Billion USD | 99.659% |
| Nephros, Inc. | 3.5 Million USD | -9.221% |
| NovoCure Limited | 783.63 Million USD | 99.512% |
| NEXGEL, Inc. | 4.78 Million USD | 20.109% |
| NEXGEL, Inc. | 4.78 Million USD | 20.109% |
| Singular Genomics Systems, Inc. | 86.46 Million USD | 95.575% |
| OraSure Technologies, Inc. | 52.17 Million USD | 92.667% |
| Pro-Dex, Inc. | 23.34 Million USD | 83.61% |
| Pulse Biosciences, Inc. | 16.44 Million USD | 76.733% |
| Predictive Oncology Inc. | 6.14 Million USD | 37.743% |
| Precision Optics Corporation, Inc. | 6.84 Million USD | 44.103% |
| QuidelOrtho Corporation | 3.55 Billion USD | 99.892% |
| Repligen Corporation | 853.2 Million USD | 99.552% |
| Sanara MedTech Inc. | 29.28 Million USD | 86.934% |
| STAAR Surgical Company | 102.73 Million USD | 96.276% |
| Sharps Technology, Inc. | 3.85 Million USD | 0.752% |
| Utah Medical Products, Inc. | 7.14 Million USD | 46.452% |
| DENTSPLY SIRONA Inc. | 4.07 Billion USD | 99.906% |
| Jin Medical International Ltd. | 8.92 Million USD | 57.129% |